The 2022 Inflation Reduction Act (IRA) has introduced significant challenges for the pharmaceutical industry, altering the ...

Gilead Sciences (NASDAQ:GILD) and Terray Therapeutics have entered into a strategic collaboration to discover and develop ...

Life sciences companies are the backbone of our local economy and develop life-changing medications and therapies for ...

Scientists from the Miller School of Medicine at the University of Miami have reported their recent work to develop small-molecule inhibitors of the CD40-CD40L (CD154) costimulatory protein-protein ...

DeepCure, a therapeutics company using AI to discover novel therapies for inflammation and immune diseases, announced today ...

Gilead (GILD) and Terray Therapeutics announced that the companies have entered into a strategic collaboration to discover ...

Two types of amylin-based treatments for the treatment of obesity are currently being developed: dual amylin and calcitonin receptor agonists (DACRAs) that target both the amylin and calcitonin ...